779 related articles for article (PubMed ID: 23935243)
1. LOX-1, OxLDL, and atherosclerosis.
Pirillo A; Norata GD; Catapano AL
Mediators Inflamm; 2013; 2013():152786. PubMed ID: 23935243
[TBL] [Abstract][Full Text] [Related]
2. LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
Chistiakov DA; Orekhov AN; Bobryshev YV
Cell Physiol Biochem; 2016; 38(5):1851-9. PubMed ID: 27160316
[TBL] [Abstract][Full Text] [Related]
3. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
Singh S; Gautam AS
Curr Atheroscler Rep; 2019 Jul; 21(10):38. PubMed ID: 31350594
[TBL] [Abstract][Full Text] [Related]
4. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
Chen M; Masaki T; Sawamura T
Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130
[TBL] [Abstract][Full Text] [Related]
5. The discovery of LOX-1, its ligands and clinical significance.
Yoshimoto R; Fujita Y; Kakino A; Iwamoto S; Takaya T; Sawamura T
Cardiovasc Drugs Ther; 2011 Oct; 25(5):379-91. PubMed ID: 21805404
[TBL] [Abstract][Full Text] [Related]
6. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.
Hossain E; Ota A; Karnan S; Takahashi M; Mannan SB; Konishi H; Hosokawa Y
Mol Cell Biochem; 2015 Feb; 400(1-2):29-40. PubMed ID: 25348362
[TBL] [Abstract][Full Text] [Related]
8. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis.
Di Pietro N; Formoso G; Pandolfi A
Vascul Pharmacol; 2016 Sep; 84():1-7. PubMed ID: 27256928
[TBL] [Abstract][Full Text] [Related]
9. Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).
Renie G; Maingrette F; Li L
Curr Diabetes Rev; 2007 May; 3(2):103-10. PubMed ID: 18220661
[TBL] [Abstract][Full Text] [Related]
10. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH
Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724
[TBL] [Abstract][Full Text] [Related]
11. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
12. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.
Mattaliano MD; Huard C; Cao W; Hill AA; Zhong W; Martinez RV; Harnish DC; Paulsen JE; Shih HH
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1329-37. PubMed ID: 19279231
[TBL] [Abstract][Full Text] [Related]
13. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.
Xu S; Ogura S; Chen J; Little PJ; Moss J; Liu P
Cell Mol Life Sci; 2013 Aug; 70(16):2859-72. PubMed ID: 23124189
[TBL] [Abstract][Full Text] [Related]
14. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease.
Akhmedov A; Sawamura T; Chen CH; Kraler S; Vdovenko D; Lüscher TF
Eur Heart J; 2021 May; 42(18):1797-1807. PubMed ID: 36282110
[TBL] [Abstract][Full Text] [Related]
15. Hyperoside inhibits the effects induced by oxidized low-density lipoprotein in vascular smooth muscle cells via oxLDL-LOX-1-ERK pathway.
Zhang Z; Zhang D; Du B; Chen Z
Mol Cell Biochem; 2017 Sep; 433(1-2):169-176. PubMed ID: 28434118
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway.
Chen B; Li J; Zhu H
Vascul Pharmacol; 2016 Oct; 85():1-10. PubMed ID: 26297684
[TBL] [Abstract][Full Text] [Related]
17. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
[TBL] [Abstract][Full Text] [Related]
18. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α
Kanaoka Y; Koga M; Sugiyama K; Ohishi K; Kataoka Y; Yamauchi A
Toxicology; 2017 Apr; 380():62-71. PubMed ID: 28202387
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
[TBL] [Abstract][Full Text] [Related]
20. Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression.
Thampi P; Stewart BW; Joseph L; Melnyk SB; Hennings LJ; Nagarajan S
Atherosclerosis; 2008 Apr; 197(2):620-9. PubMed ID: 17950295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
